AKNEMYCIN PLUS

This brand name is authorized in Poland, Singapore, United Kingdom

Active ingredients

The drug AKNEMYCIN PLUS contains a combination of these active pharmaceutical ingredients (APIs):

1 Erythromycin UNII 63937KV33D - ERYTHROMYCIN

Erythromycin exerts its antimicrobial action by binding to the 50S ribosomal sub-unit of susceptible microorganisms and suppresses protein synthesis. Erythromycin is bacteriostatic and bactericidal depending on its concentration and the type of organism. Read about Erythromycin

2 Tretinoin UNII 5688UTC01R - TRETINOIN

Tretinoin decreases cohesiveness of follicular epithelial cells resulting in decreased microcomedone formation. Additionally, tretinoin stimulates mitotic activity and increased turnover of follicular epithelial cells, causing extrusion of the comedones. Read about Tretinoin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
AKNEMYCIN PLUS Cutaneous solution	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
D10AF52	Erythromycin, combinations	D Dermatologicals → D10 Anti-acne preparations → D10A Anti-acne preparations for topical use → D10AF Antiinfectives for treatment of acne
Discover more medicines within D10AF52

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 38448
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100095799, 100248620, 100286921, 100293424, 100324202, 100330600, 100443711
Country: SG	Health Sciences Authority	Identifier(s): 11276P